Effectiveness of ERCP in cholangitis: a community-based study

Area of Science:

• Gastroenterology and Hepatology
• Interventional Endoscopy
• Biliary Tract Diseases

Background:

• The efficacy of endoscopic retrograde cholangiopancreatography (ERCP) in treating cholangitis is established, but its effectiveness in unselected patient populations requires further investigation.
• This study addresses the need to evaluate the clinical impact of ERCP, both overall and early intervention, in patients primarily diagnosed with cholangitis.

Purpose of the Study:

• To investigate the clinical impact of ERCP performed at any time during hospitalization for cholangitis.
• To assess the specific effectiveness of early ERCP (within 24 hours of admission) in managing cholangitis patients.

Main Methods:

• Retrospective analysis of 116 patients admitted with International Classification of Diseases (ICD)-9 diagnoses consistent with cholangitis across eight hospitals.
• Data collected included clinical characteristics, ERCP findings, and patient outcomes.
• Multivariate analysis was employed to adjust for confounding factors such as illness severity, cholangitis etiology, and hospital type, examining the association of ERCP with length of stay.

Main Results:

• ERCP was performed in 71 patients, with 80% receiving endoscopic therapy.
• While ERCP overall did not alter hospital stay, it was associated with a shorter stay compared to other invasive biliary procedures (median 5 vs. 9.5 days).
• Early ERCP (within 24 hours) resulted in a significantly shorter hospital stay (median 4 vs. 7 days) and a 34% reduction in severity-adjusted length of stay compared to delayed ERCP.

Conclusions:

• Early ERCP demonstrates a significant benefit in reducing hospital length of stay for patients admitted with cholangitis.
• The findings suggest that timely ERCP is an effective strategy for optimizing patient management and resource utilization in cholangitis cases.